Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Plants (Basel) ; 13(4)2024 Feb 15.
Article in English | MEDLINE | ID: mdl-38498539

ABSTRACT

During 2021 and 2022, eight field-collected and five laboratory Helicoverpa zea strains with varying susceptibility to different Bt proteins were evaluated for their responses against HearNPV using diet-overlay bioassays. The five laboratory strains included SS (susceptible to all Bt proteins), CRY-RR (resistant to Cry1 and Cry2), VIP-RR-70 (resistant to Vip3Aa), VIP-RR-15 (resistant to Vip3Aa), and TRE-RR (resistant to Cry1, Cry2, and Vip3Aa). Our findings showed that the susceptibility of TRE-RR, VIP-RR-70, and VIP-RR-15 strains to HearNPV was similar to that of the SS strain. However, the field and Cry-RR strains were more resistant to HearNPV compared to the SS strain. Because most feral H. zea strains in the southern U.S. have developed practical resistance to Cry Bt proteins but remain susceptible to Vip3Aa, the results suggest that the reduced susceptibility to HearNPV in H. zea may be associated with the resistance to Cry Bt proteins but not with the resistance to Vip3Aa. Correlation analysis confirmed that there was a significant positive relationship between Cry resistance and HearNPV resistance, but not between the Vip3Aa resistance and HearNPV resistance in H. zea. Our findings provide valuable insights into the relationship between susceptibility to HearNPV and resistance to Bt proteins in H. zea.

2.
Insects ; 13(9)2022 Sep 09.
Article in English | MEDLINE | ID: mdl-36135521

ABSTRACT

The marked adoption of bioinsecticides in Brazilian agriculture in recent years is, at least partially, explained by the increasingly higher levels of insect pest resistance to synthetic insecticides. In particular, several baculovirus-based products have been registered in the last 5 years, including Helicoverpa armigera nucleopolyhedrovirus (HearNPV: Baculoviridae: Alphabaculovirus (Armigen®)). Understanding the susceptibility of Helicoverpa armigera (Hübner) (Lepidoptera: Noctuidae) to HearNPV is an important step toward development of robust Integrated Pest Management (IPM) and Insect Resistance Management programs (IRM) aimed at managing this serious insect pest. In this study, droplet feeding bioassays were used to characterize the baseline susceptibility to HearNPV (Armigen®) in H. armigera populations collected from major soybean and cotton-growing regions in Brazil. We defined and validated a diagnostic concentration for susceptibility monitoring of H. armigera populations to HearNPV. Additionally, cross-resistance between HearNPV and the insecticides flubendiamide and indoxacarb was evaluated by testing HearNPV in a susceptible strain and in resistant strains of H. armigera to these insecticides. A low interpopulation variation of H. armigera to HearNPV was detected. The LC50 values ranged from 1.5 × 105 to 1.1 × 106 occlusion bodies (OBs) per mL (7.3-fold variation). The mortality rate at the identified diagnostic concentration of 6.3 × 108 OBs/mL, based on the calculated LC99, ranged from 98.6 to 100% in populations of H. armigera collected from 2018 to 2020. No cross-resistance was detected between HearNPV and flubendiamide or indoxacarb. These results suggest that HearNPV (Armigen®) can be an effective tool in IPM and IRM programs to control H. armigera in Brazil.

3.
Pest Manag Sci ; 68(1): 83-91, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21714059

ABSTRACT

BACKGROUND: Development of pyriproxyfen and neonicotinoid resistance in the B-biotype whitefly and recent introduction of the Q biotype have the potential to threaten current whitefly management programs in Arizona. The possibility of integrating the novel anthranilic diamides chlorantraniliprole and cyantraniliprole into the current program to tackle these threats largely depends on whether these compounds have cross-resistance with pyriproxyfen and neonicotinoids in whiteflies. To address this question, the authors bioassayed a susceptible B-biotype strain, a pyriproxyfen-resistant B-biotype strain, four multiply resistant Q-biotype strains and 16 B-biotype field populations from Arizona with a systemic uptake bioassay developed in the present study. RESULTS: The magnitude of variations in LC(50) and LC(99) among the B-biotype populations or the Q-biotype strains was less than fivefold and tenfold, respectively, for both chlorantraniliprole and cyantraniliprole. The Q-biotype strains were relatively more tolerant than the B-biotype populations. No correlations were observed between the LC(50) (or LC(99)) values of the two diamides against the B- and Q-biotype populations tested and their survival rates at a discriminating dose of pyriproxyfen or imidacloprid. CONCLUSION: These results indicate the absence of cross-resistance between the two anthranilic diamides and the currently used neonicotinoids and pyriproxyfen. Future variation in susceptibility of field populations to chlorantraniliprole and cyantraniliprole could be documented according to the baseline susceptibility range of the populations tested in this study.


Subject(s)
Diamide/pharmacology , Hemiptera/drug effects , Insecticides/pharmacology , ortho-Aminobenzoates/pharmacology , Animals , Arizona , Biological Assay , Female , Hemiptera/classification , Insecticide Resistance , Male
4.
Pest Manag Sci ; 65(9): 969-74, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19449341

ABSTRACT

BACKGROUND: Chlorantraniliprole is a novel anthranilic diamide insecticide, efficacious for control of lepidopteran insect pests, as well as some species in the orders Coleoptera, Diptera and Hemiptera. In this study, the speed of action of chlorantraniliprole was compared with that of seven commercial insecticides by means of ingestion bioassays against larvae of Plutella xylostella L., Trichoplusia ni (Hübner), Spodoptera exigua (Hübner) and Helicoverpa zea (Boddie). RESULTS: Based on feeding cessation and reduction in feeding damage, chlorantraniliprole is among the fastest-acting insecticides available for control of lepidopteran pests, comparable in speed of action with methomyl, lambda-cyhalothrin and esfenvalerate, and faster than emamectin benzoate, indoxacarb, methoxyfenozide and metaflumizone. CONCLUSION: The speed of action of chlorantraniliprole against target pest species, based on time for feeding cessation and reduction in feeding damage, is significantly greater than that of most recently developed insecticides and comparable only with the speed of action of the fast-acting carbamates and pyrethroids. In addition, chlorantraniliprole has a favorable toxicological and ecotoxicological profile. It belongs to a new chemical class with a novel mode of action and is effective against insect populations that have developed resistance to other insecticide groups, thus representing an attractive new tool for integrated pest management programs.


Subject(s)
Insecta/drug effects , Insecta/physiology , Insecticides/pharmacology , ortho-Aminobenzoates/pharmacology , Animals , Feeding Behavior/drug effects , Larva/drug effects , Larva/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...